15630849

Source:http://linkedlifedata.com/resource/pubmed/id/15630849

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001675, umls-concept:C0006826, umls-concept:C0038952, umls-concept:C0677881, umls-concept:C1880177
pubmed:issue	8
pubmed:dateCreated	2005-1-5
pubmed:abstractText	The debate on the funding and availability of cytotoxic drugs raises questions about the contribution of curative or adjuvant cytotoxic chemotherapy to survival in adult cancer patients.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15630849-15997929
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9002902
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0936-6555
pubmed:author	pubmed-author:BartonMichaelM, pubmed-author:MorganGraemeG, pubmed-author:WardRobynR
pubmed:issnType	Print
pubmed:volume	16
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	549-60
pubmed:dateRevised	2008-3-10
pubmed:meshHeading	pubmed-meshheading:15630849-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15630849-Australia, pubmed-meshheading:15630849-Humans, pubmed-meshheading:15630849-Neoplasms, pubmed-meshheading:15630849-Prognosis, pubmed-meshheading:15630849-Randomized Controlled Trials as Topic, pubmed-meshheading:15630849-SEER Program, pubmed-meshheading:15630849-Survival Analysis
pubmed:year	2004
pubmed:articleTitle	The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies.
pubmed:affiliation	Department of Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW, Australia. gmorgan1@bigpond.net.au
pubmed:publicationType	Journal Article, Review